| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $50K | +257.1% |
| R&D Expense | $20.7M | -37.7% |
| SG&A Expense | $10.3M | +8.2% |
| Operating Income | -$47.4M | -11.1% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | $45.9M | +9.2% |
| Net Income | -$45.9M | -9.2% |
| EPS (Basic) | -$1.86 | +11.8% |
| EPS (Diluted) | -$1.86 | +11.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.8M | +18.3% |
| Accounts Receivable | $4.3M | +262.7% |
| Current Assets | $29.9M | +31.9% |
| Total Assets | $32.4M | -18.2% |
| Current Liabilities | $8.4M | +16.5% |
| Long-term Debt | $15.0M | +0.0% |
| Total Liabilities | $8.8M | +18.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.6M | +32.3% |
| Capital Expenditures | $1.0M | — |
| Investing Cash Flow | -$1.0M | — |
| Financing Cash Flow | $27.6M | +51.6% |
| Free Cash Flow | -$23.6M | — |
| $23.5M |
| -26.7% |